SINGAPORE - TelAve -- FILMTACK PTE LTD (FILMTACK), a Singapore-based window film company has developed an anti-fog Face Shield visor film with additional protection against bacteria such as E-Coli, Staphylococcus aureus in response to the COVID-19 pandemic.

The faces of healthcare workers have been reported to be the body-part most commonly contaminated by body fluids.

As COVID-19 restrictions are easing in the days ahead, FILMTACK Director, K. H. Poon, sees the new product as an improved material for Face Shield visors, providing better protection against aerosols and mucous membranes for high-risk groups such as healthcare workers and students.

"Research institutions around the world have been focusing on the development of anti-microbial chemicals but lack the capability to move forward and incorporate these coatings onto face shield visors correctly and efficiently," said Poon.

More on TelAve News

• $12.8 Million Net Revenue for 2024 for Cloud-Based Crowdsourcing Recruitment and SaaS-Enabled HR Solutions Provider: Baiya International Group Inc
• Hire Virtue Announces Executive Sponsorship Opportunity for Houston Hiring Blitz & Job Fair on August 6, 2025
• Inked & Maxim Model Teisha Mechetti Turns Heads—And Builds Community Impact
• Plan to Launch Silo Technologies' Cybersecurity Pilot Program for Ultimate Nationwide Deployment via Exclusive Partnership: Stock Symbol: BULT
• Robert Michael & Co. Real Estate Team Celebrates Industry Recognition and Showcases Premier Central Florida Listings

Commenting on the background behind the development of the visor film, Poon explained "We have been trying to produce a shower screen safety film. While our anti-fog agent is among the best in the industry, the product has not been launched because the function is limited to eight months in a highly humid environment. When we laid our hands on an anti-microbial compound that was better than most traditional solutions that used active ingredients, we began working with our JV partners to integrate it with our existing anti-fog technology."

With simple sterilizing, the functionality of the visor film is expected to last about 10-14 days. The material has generated interest from US and Korean Personal Protective Equipment (PPE) manufacturers; seeking customized thickness of high optical-clarity material with reliable anti-microbial and anti-fog protection.

Lately, the window film industry has been at the forefront of producing quality visor films for the PPE industry. Like FILMTACK, many reputable window film companies have swiftly invested in relevant research and production to improve the quality of face shield visor materials since early 2020.

More on TelAve News

• AI-Based Neurotoxin Countermeasure Initiative Launched to Address Emerging National Security Needs: Renovaro, Inc. (N A S D A Q: RENB)
• The Naturist World Just Shifted — NaturismRE Ignites a Global Resurgence
• Ace8 Launches Cutting-Edge Observability Service to Empower Modern IT Operations
• AceMQ Unveils Advanced Containerization Solutions to Accelerate Digital Transformation
• $796,000 in Q2 Revenue Marks Highest Earnings to Date on 3 Trailing Quarters of Profitability in Multi-Billion Homebuilding Sector: Stock Symbol: IVDN

Going forward, FILMTACK also expects niche-market demand for clear anti-microbial and anti-fog films in the manufacturing of transparent face masks, which will improve interpersonal visual-communications in schools and workplaces.

About FILMTACK

FILMTACK is a leading window film company in Asia-Pacific, focused on improving product performance and empowering window film businesses in the industry. Through its subsidiaries, associates and joint ventures, FILMTACK is engaged in the development and application of advanced ceramics and sputtering technology in window films. The firm's specialization includes glare-reduction, HEV-Light protection, infra-red filtering coatings for advanced materials.

For more information, please visit www.filmtack.com